This medicine works as a GLP-1 and GIP receptor agonist, facilitating drug administration
The Ozempic pill is replacing Novo Nordisks Rybelsus daily oral medication, which was approved in 2019 for type 2 diabetes by the Food and Drug Administration (FDA) in 3 milligram (mg), 7 mg, and 14 mg doses
It helps: Convert food into usable energy (adenosine triphosphate or ATP) Support hundreds of metabolic reactions Maintain healthy mitochondrial function Facilitate DNA repair and gene expression Activate sirtuins, proteins that regulate aging processes Combat cognitive decline and support brain cells You can learn more about NAD+ functions and how it supports overall wellness through its role in cellular energy production and longevity pathways
Dentists say that dry mouth, vomiting, and low appetite are likely causes of these side effects
But it can be helpful to reframe this narrative a bit: the healthy habits youre working on now are likely very similar to the healthy habits other people are trying to develop
GLP-1 receptor agonists have been shown in clinical studies to support meaningful and sustained weight loss when used alongside lifestyle changes such as improved diet, regular physical activity, and ongoing medical supervision